Variant report
Variant | nsv516240 |
---|---|
Chromosome Location | chr5:103443156-103450790 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs372678983 | chr5:103446612-103446613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs142742256 | chr5:103446672-103446673 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs553648445 | chr5:103446721-103446722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs201896084 | chr5:103446723-103446724 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs201387780 | chr5:103446730-103446731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs79053358 | chr5:103446734-103446735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs529935010 | chr5:103446747-103446748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs73775530 | chr5:103446781-103446782 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs567003743 | chr5:103446785-103446786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs143874037 | chr5:103446841-103446842 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs71593280 | chr5:103446844-103446845 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs538646568 | chr5:103446848-103446849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs558957562 | chr5:103446857-103446858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs569161113 | chr5:103446871-103446872 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs376945489 | chr5:103446908-103446909 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs11957443 | chr5:103446917-103446918 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs574666289 | chr5:103447063-103447064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs115964260 | chr5:103447068-103447069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs192914257 | chr5:103447151-103447152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs183615617 | chr5:103447152-103447153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs544777943 | chr5:103447169-103447170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs7725285 | chr5:103447183-103447184 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs142301140 | chr5:103447200-103447201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs576518407 | chr5:103447221-103447222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs544489153 | chr5:103447253-103447254 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs543423427 | chr5:103447274-103447275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs565573906 | chr5:103447275-103447276 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs529898294 | chr5:103447340-103447341 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs376229575 | chr5:103447376-103447377 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs532654987 | chr5:103447448-103447449 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs566849480 | chr5:103447478-103447479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs532592111 | chr5:103447495-103447496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs188156340 | chr5:103447541-103447542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs559267760 | chr5:103447546-103447547 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs548059336 | chr5:103447572-103447573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs78016808 | chr5:103447584-103447585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs192863954 | chr5:103447689-103447690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs568450869 | chr5:103447700-103447701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs377484195 | chr5:103447710-103447711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs559566595 | chr5:103447716-103447717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs150985997 | chr5:103447732-103447733 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs577373070 | chr5:103447744-103447745 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs538690097 | chr5:103447777-103447778 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs139363933 | chr5:103447794-103447795 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs375937673 | chr5:103447795-103447796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs558389404 | chr5:103447796-103447797 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs10601014 | chr5:103450416-103450417 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs373374244 | chr5:103450417-103450418 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs201817271 | chr5:103450418-103450419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs527438929 | chr5:103450425-103450426 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 16608533 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:103446600-103447200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
2 | chr5:103447000-103447600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr5:103447000-103447800 | Enhancers | Primary neutrophils fromperipheralblood | blood |
4 | chr5:103450400-103457600 | Weak transcription | K562 | blood |